1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > Medline Industries, Inc. - Strategy and SWOT Report

Medline Industries, Inc. - Strategy and SWOT Report

  • December 2015
  • -
  • MarketLine
  • -
  • 24 pages

Introduction

Medline Industries, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Features:

- Detailed information on Medline Industries, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Medline Industries, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Medline Industries, Inc. including a breakdown and examination of key business segments

- Intelligence on Medline Industries, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Medline Industries, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Medline Industries, Inc. (Medline or 'the company') is a privately-held provider of healthcare supplies and equipment. The company manufactures and distributes medical and surgical products to healthcare institutions and retail outlets. Medline primarily operates in the US. It is headquartered in Mundelein, Illinois and employs more than 12,000 people. The company recorded revenues of more than $7,000 million during 2014. Medline is a privately-held company and does not publish its financial results.

Reasons to Purchase:

- Gain understanding of Medline Industries, Inc. and the factors that influence its strategies

- Track strategic initiatives of the company and latest corporate news and actions

- Assess Medline Industries, Inc. as a prospective partner, vendor or supplier

- Support sales activities by understanding your customers' businesses better

- Stay up to date on Medline Industries, Inc.’s business structure, strategy and prospects

Table Of Contents

Medline Industries, Inc. - Strategy and SWOT Report
Company Overview
Business Description
History
Key Employees and Biographies
Company View
Locations and Subsidiaries
SWOT Analysis
Revenue Analysis
Key Competitors
Major Products and Services

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2016

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘NT-3 ...

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global ...

Hospital for Special Surgery - Product Pipeline Analysis, 2016 Update

Hospital for Special Surgery - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • December 2016
  • by GlobalData

Summary Hospital for Special Surgery (HSS) is a healthcare service provider that provides surgery services in the areas of orthopedics, rehabilitation and rheumatology. The hospital discovers and develops ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.